Thrombolytic therapy for acute stroke in Austria: Data from the Safe Implementation of Thrombolysis in Stroke (SITS) register

European Journal of Neurology

Volumn 18, Issue 2, 2011, Pages 306-311

  Topakian, R ^a   Brainin, M ^b,c   Eckhardt, R ^b,c   Kiechl, S ^d   Ahmed, N ^e   Ferrari, J ^f   Iglseder, B ^g   Wahlgren, N G ^e   Lang, W ^f   Fazekas, F ^h   Willeit, J ^d   Aichner, F T ^a  

^a KEPLER UNIVERSITY HOSPITAL   (Austria)

^b Landesklinikum Donauregion Tulln ^*  (Austria)

^c DANUBE UNIVERSITY KREMS   (Austria)

^d INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f Hospital Barmherzige Brueder Vienna   (Austria)

^g PARACELSUS MEDICAL UNIVERSITY   (Austria)

^h UNIVERSITY HOSPITAL GRAZ   (Austria)

Author keywords

Mortality; Outcome; Safety; Stroke; Thrombolysis

Indexed keywords

ALTEPLASE;

ADULT; AGED; ARTICLE; AUSTRIA; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; STROKE;

AGED; AUSTRIA; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; REGISTRIES; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 78751517259     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2010.03141.x     Document Type: Article

References (24)

1. Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363: 768-774.
2. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-1587.
3. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995; 274: 1017-1025.
4. Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998; 352: 1245-1251.
5. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 1999; 282: 2019-2026.
6. Clark WM, Albers GW, Madden KP, Hamilton S. The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g): results of a double-blind, placebo-controlled, multicenter study. Thrombolytic therapy in acute ischemic stroke study investigators. Stroke 2000; 31: 811-816.
7. Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007; 369: 275-282.
8. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359: 1317-1329.
9. Wahlgren N, Ahmed N, Dávalos A, et al. Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet 2008; 372: 1303-1309.
10. SITS-ISTR (Safe Implementation of Thrombolysis in Stroke - International Stroke Thrombolysis Register). Available at: Accessed November 10, 2009.
11. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJA, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19: 604-607.
12. Steiner MM, Brainin M, Austrian Stroke Registry for Acute Stroke Units. The quality of acute stroke units on a nation-wide level: the Austrian Stroke Registry for acute stroke units. Eur J Neurol 2003; 10: 353-360.
13. Kent DM, Selker HP, Ruthazer R, Bluhmki E, Hacke W. The stroke-thrombolytic predictive instrument: a predictive instrument for intravenous thrombolysis in acute ischemic stroke. Stroke 2006; 37: 2957-2962.
14. Kent DM, Selker HP, Ruthazer R, Bluhmki E, Hacke W. Can multivariable risk-benefit profiling be used to select treatment-favorable patients for thrombolysis in stroke in the 3- to 6-hour time window? Stroke 2006; 37: 2963-2969.
15. Wahlgren N, Ahmed N, Eriksson N, et al. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST). Stroke 2008; 39: 3316-3322.
16. The Lancet Neurology. An acute need for better stroke care. Lancet Neurol 2007; 6: 571.
17. Ringelstein EB, Meckes-Ferber S, Hacke W, et al. European stroke facilities survey: the German and Austrian perspective. Cerebrovasc Dis 2009; 27: 138-145.
18. Leys D, Ringelstein EB, Kaste M, Hacke W, Executive Committee of the European Stroke Initiative. Facilities available in European hospitals treating stroke patients. Stroke 2007; 38: 2985-2991.
19. Stroke Unit Trialists' Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev 2007; 4: CD000197.
20. Brainin M, Steiner M, Austrian Stroke Registry for Acute Stroke Units. Acute stroke units in Austria are being set up on a national level following evidence-based recommendations and structural quality criteria. Cerebrovasc Dis 2003; 15(Suppl. 1): 29-32.
21. Brainin M, Lang W. Editorial: stroke units in Austria. structure, performance and results. Wien Med Wochenschr 2008; 158: 407-410.
22. Leys D, Ringelstein EB, Kaste M, Hacke W, European Stroke Initiative Executive Committee. The main components of stroke unit care: results of a European expert survey. Cerebrovasc Dis 2007; 23: 344-352.
23. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008; 25: 457-507.
24. Hofer C, Kiechl S, Lang W. The Austrian Stroke-Unit-Registry. Wien Med Wochenschr 2008; 158: 411-417.